Avricore Health (TSE:AVCR) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Avricore Health Inc. reported a significant rise in revenues and profitability for the third quarter of 2024, with a 58% year-over-year revenue increase. The company is strategically expanding its HealthTab™ services in the UK, capitalizing on the region’s strong investment in pharmacy-led healthcare services.
For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.